Your session is about to expire
← Back to Search
Behavioral, Psychological or Informational Intervention for Lung Cancer
N/A
Waitlist Available
Led By Barbara Andersen, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months post-treatment
Awards & highlights
Study Summary
This trial is studying a treatment for stress, depression, and anxiety in patients with stage IV lung cancer. The treatment is a combination of biobehavioral intervention and cognitive therapy.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 months post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months post-treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability, measured by Patient Satisfaction Survey (PSS)
Biospecimen analysis: Inflammation (Interleukin-6)
Biospecimen analysis: Neutrophil/lymphocyte ratio (NLR)
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Supportive care (ABC session, surveys, biospecimen collection)Experimental Treatment5 Interventions
Phase 1 of the intervention (10 weeks) will follow the following agenda: 1) Overview and progressive muscle relaxation, 2) Seeking and asking for disease-related and treatment-related information, 3) Problem solving skills, 4) Breathing techniques and sleep hygiene, 5) Assertive communication skills, 6) Identifying social network, 7) Asking for support, 8) Further information on social support, 9) Physical activity, and 10) Review of major topics, transition. Phase 2 of the intervention (4 weeks) which will be completed only by patients who do not experience remission in depressive symptoms by the end of phase 1, will follow the following agenda: 1) Identifying negative thoughts and problematic thinking patterns, 2) Generating alternative thoughts, 3) Behavioral activation, and 4) Review and wrap-up, transition to optional maintenance. Each session in Phase 1 and Phase 2 occurs once per week, for 60 minutes each. Maintenance sessions occur monthly, 60 minutes each.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1730
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,137 Total Patients Enrolled
Barbara Andersen, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
3 Previous Clinical Trials
116 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are at high risk of committing suicide and cannot receive treatment as an outpatient.You are experiencing significant levels of depression and/or anxiety, as determined by questionnaire scores.You are currently receiving therapy or counseling for a psychological condition.You will be receiving both chemotherapy and radiation therapy as your main form of treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive care (ABC session, surveys, biospecimen collection)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this clinical trial available to the public?
"Affirmative. The information hosted on clinicaltrials.gov confirms that this medical trial is open for enrollment and recruiting patients from one location. This study was first published on June 1st 2021, with the latest update being made on April 18th 2022. 40 participants are required to take part in the experiment."
Answered by AI
What is the upper limit of participants in this medical experiment?
"Affirmative. Clinicaltrials.gov reveals that, since its inception on June 1st 2021 and last update on April 18th 2022, this clinical trial is actively seeking out 40 individuals from a single medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger